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Purpose: The early outcomes of carotid endarterectomy (CEA) with primary closure (PC) 
versus vein patch closure (saphenous vein [SVP] and jugular vein [JVP]) and polytetra- 
fluoroethylene patch closure (PTFE-PC) were compared. 
Methods: Three hundred ninety-nine CEAs were randomized into the following groups: 
135 PC, 134 PTFE-PC, and 130 vein patch dosure (SVP alternating with JVP). 
Surviving patients underwent a carotid color duplex ultrasonographic scan I month after 
surgery. Demographic characteristics were similar in all groups. 
Results: The incidence ofperioperative c rebrovascular accidents (CVAs) was 4.4% for PC, 
0.8% for PTFE-PC, and 0% for vein patch closure (PC vs vein patch, p = 0.0165; PC vs all 
patching [vein and PTFE], p = 0.007). The perioperative CVA and reversible ischemic 
neurologic deficit (RIND) combined rates for all patching were superior to PC (1.5% vs 
5.2%; p = 0.04). These combined rates were also superior for vein patch closure when 
compared with PC (0.8% vs 5.2%; p = 0.037). The mean diameter of the internal carotid 
artery was similar in patients who had perioperative neurologic deficits and those who did 
not. After I month of follow-up, 11.9% of the PC arteries were narrowed 50% or more in 
contrast to 2.3% for PTFE-PC, 3.1% for SVP, and 10.3% for JVP (PC vs all patching, p = 
0.008; PC vs PTFE-PC, p = 0.0017; PC vs SVP, p = 0.028). In contrast, early 
postoperative dilation of the internal carotid artery to more than twice the measured 
diameter was not significantly higher in patched arteries than in PC arteries. The mean 
operative and hemostasis times were significantly longer for patching than for PC. 
Conclusions: Patch closure is less likely than PC to cause perioperative CVA, RIND, and 
early internal carotid artery stenosis. (J Vasc Surg 1996;24:998-1007.) 
It  has long been recognized that performing ca- 
rotid endarterectomy (CEA) is superior to giving 
medical therapy in decreasing the risk of stroke; how- 
ever, the type of  closure after CEA, primary closure 
(PC) or patch angioplasty, remains controversial, ld6 
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The selection of patch material is also controversial, 
with supporters for the use of  both vein patch (saphe- 
nous or neck veins) and synthetic patch materials 
(polytetrafluoroethylene [PTFE] or Dacron). Propo- 
nents of  vein patch angioplasty state that the theoretic 
benefits include increasing luminal size and providing 
endothelialized tissue to the endarterectomized ar-
eas. By performing this function, it is believed that 
the risk of perioperative stroke and asymptomatic 
occlusion is reduced, s 7,8 
Although several studies have compared the re- 
suits of PC with saphenous vein patch closure 
(SVp)3 5,7-9,i2,13 with PTFE patch closure (PTFE- 
PC) 8,1i,14 and with jugular vein patch closure 
(JVP), ls,i6 no prospective, randomized, controlled 
trials have compared the results of  CEA with PC 
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versus PTFE-PC versus SVP closure versus JVP clo- 
sure in one series. 
This study's primary purpose was to compare the 
perioperative stroke rates t cerebrovascular ccidents 
[CVAs] ~ among patients who had PC, PTFE closure, 
or vein patch closure rSVP or JVP) of CEA. Other 
comparisons of outcomes were explored. This paper 
includes only the immediate arly perioperative r - 
sults (30-day morbidity and mortality rates ~ for each 
group. Follow-up of these patients is continuing for 
late complications and the iong-term patency of the 
CEA. 
PAT IENTS AND METHODS 
Between October 199i and November 1995, 
399 CEAs (357 patients) were entered into this 
study. This number included 315 patients who un- 
derwent unilateral procedures and 42 patients who 
underwent bilateral procedures. Patients were asked 
to participate in this prospective randomized trial of 
CEA with PC versus PTFE-PC versus vein patch 
closure (VPC; SVP alternating with JVP). Patients 
who were scheduled for a repeat CEA, for CEA with 
concomitant coronary artery bypass grafting, or pa- 
tients who had internal carotid artery (ICA) diame- 
ters less than 4~ mm were excluded t12 CEAs, 3%). 
This study was approved by the Institutional Review 
Board of  Charleston Area Medical Center/Robert  C.
Byrd Health Sciences Center of West Virginia Uni- 
versitv. 
Before surgery, all patients underwent carotid 
color duplex ultrasound scans and angiographic stud- 
ies to determine preoperative stenoses. They also 
underwent tests for baseline blood cholesterol and 
triglyceride l vels. Preoperative risk factors, including 
hypertensiom diabetes mellitus, coronary artery dis- 
ease, and smoldng, were determined for each patient, 
along with the preoperative use of aspinn or dipyn- 
damole. The indications for surgery were categorized 
into hemispheric transient ischemic attack (TIA), am+ 
aurosis fugax, hemispheric CVA, nonhemispheric 
TIA, and asymptomatic carotid stenosls or carotid 
bruit. 
Randomization included 135 PCs, 134 PTFE- 
PCs, and 130 VPCs (70 SVP and 60 JVP L In the vein 
group, seven assigned neck vein cases were not done. 
Four of these were changed to PC, for no specific 
reason, by the assigned surgeon, and these proce- 
dures were consequently excluded from the study; 
three were changed to SVP closure as a result of an 
unsuitable jugular vein in two cases and a radical neck 
dissection in one case, mad these proccdures were 
included in the study. 
Operative technique. All CEAs were performed 
with the patient under general anesthesia with sys- 
temic heparin and routine shunting using a carotid 
Argyle shunt (C.R. Bard. Inc., Bilterica, Mass.). No 
protamine was given at the end of the procedure. At 
the time of surgery, the normal ICA distal to the 
lesion was measured in millimeters using calipers. 
Patients who had an ICA exterior diameter less than 
4.0 mm were routinely excluded from this study and 
underwent patch angioplasty. Endarterectomies were 
extended proximally and distally beyond grossly dis- 
eased intima. 
PC was achieved using 6-0 polypropylene suture 
material (Prolene; Ethicon, Inc.. Somerville, N.J.). 
For SVP closure, the greater saphenous vein was 
harvested at the level of the medial malleolus, and a 4- 
to 5-mm-wide patch was used and closed with the 
same 6-0 Prolene suture material. The cephalad end 
of the carotid arteriotomy was extended a few milli- 
meters beyond the endarterectomy to allow the onlay 
patch to widen the distal end of the endarterectomy, 
which is potentially the narrowest part of the recom 
struction. For JVP closure, the internal jugular vein 
was localized, dividfi~g the facial vein and other trib- 
utaries~ and then the vein was clamped and divided, 
securing the stumps with suture ligatures. The patch 
was fashioned similar to the SVP and closed in a 
similar manner. The PTFE patches were fashioned 
from a 0.4-mm cardiovascular patch. The patch was 
trimmed and tapered to the appropriate size to recon- 
struct the original shape of the carotid bulb. PTFE 
sutures were used for the PTFE patch closure. 
Thrombin-soaked oxidized cellulose and digital 
pressure were applied to stop any bleeding points 
before closure, and all procedures were drained. Op- 
eranve and hemostasis gmes were recorded. All pa- 
tients started a regimen of aspirin (325 mg daily~ 
within 24 hours after surgery. 
Surveillance protocol,  The surviving patients 
were observed clinically and underwent a postopera- 
tive color duplex ultrasound scan at 30 days, 6 
months, and every 6 months thereafter using an ATL 
Ultramark 8 and 9 HDI  system (Advanced Technol- 
ogy Laboratory, Inc., Bellevue, Wash. ~. Reportable 
complications, including death, TIA. reversible isch- 
emic neurologic deficits (RIND), permanent neuro- 
logic ~ CVA5 morbidity, and asymptomatic o clusive 
events, were determined in accordance with the 
North American Chapter of the International Society 
of Cardiovascular Surgery/Society for Vascular Sur- 
gery Ad Hoc Committee Suggested Standards for 
Reports Dealing with Cerebrovascular Disease. 17 
Duplex scanning was used to assess the presence 
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Table I. Demographic and clinical data 
i Primary closure PTFE closure SVP closure JVP closure 
No. (%) No. (%) No. (%) No. (%) 
No. of CEA 135 r 134 70 60 
Sex 
Male 71 (52.6) 71 (52.9) 34 (48.6) 29 (48.3) 
Female 64 (47.4) 63 (47) 36 (51.4) 31 (51.7) 
Mean age (range) 68.4 (45 to 89) 67.9 (35 to 89) 68.0 (40 to 90) 68.2 (41 to 91) 
Smoking 84 (62.2) 74 (55.2) 42 (60) 33 (55) 
Coronary artel~¢ disease 86 (63.7) 76 (56.7) 35 (50) 36 (60) 
Hypertension 109 (80.7) 99 (73.9) 54 (77.1) 47 (78.3) 
Diabetes mellitus 34 (25.1) 36 (26.9) 17 (24.3) 12 (20) 
Preoperative cholesterol (mean) 218 220 215 214 
Preoperative triglycerides (mean) 238 248 213 216 
Preoperative antiplatelet Rx 106 (78.5) 88 (65.7) 54 (77.1) 41 (68.3) 
Mean diameter of ICA 0.55 0.54 0.53 0.54 
Standard deviation 0.08 0.08 0.06 0.08 
Indications for CEA 
Hemispheric TIA and/or 55 (40.7) 56 (41.8) 30 (42.9) 22 (36.7) 
amaurosis fugax 
Hemispheric CVA 11 (8.2) 10 (7.5) 10 (14.3) 8 (13.3) 
Nonhemisphetic TIA 24 (17.8) 23 (17.2) 9 (12.9) 9 (15) 
Asymptomatic/bruit 45 (33.3) 46 (33.6) 21 (30) 21 (35) 
of residual or recurrent stenoses and aneurysmal dila- 
tion. Frequencies above 4.5 IG-Iz (> 140 cycles/see) 
with spectral broadening throughout systole and an 
increased iastolic frequency were consistent with 
hemodynamicaliy s gnificant stenosis (-> 50% diame- 
ter reduction).18 In patients who had duplex findings 
that were consistent with -> 80% stenosis or occlusion, 
the diagnosis was confirmed with a magnetic reso- 
nance arteriogram, conventional rteriogram, or ca- 
rotid exploration. Duplex ultrasound scans were also 
used to measure the diameter of the proximal com- 
mon carotid artery (low in the neck) and the maxi- 
mum diameter of the distal common carotid artery 
(just before the bifurcation). Similarly, the proximal 
ICA diameter near its origin and the distal ICA 
diameter were measured. Significant postoperative 
dilatation was defined as a dilatation twice the diam- 
eter of the adjacent normal artery or larger. 
Statistical methods. The primary null hypothe- 
sis to be tested in this study was threefold. There was 
no difference in perioperative CVA between primary 
and PTFE closures, between primary and vein clo- 
sures, and between PTFE and vein closures. Fre- 
quency comparisons were made with Fisher's exact 
test. The threshold for statistical significance was p = 
0.05, overall. Because three primary comparisons 
were to be performed, however, the individual com- 
parison probabilities were set at p = 0.0167, on the 
basis of the Bonferroni method for correction for 
multiple comparisons. 
Other comparisons were performed as secondary 
analyses, including comparisons of other postopera- 
rive complications and comparisons of outcomes be- 
tween the two vein patching groups (SVP versus 
JVP). Continuous variables (such as operative time, 
vessel diameter, and hemostasis time) were compared 
for the various urgical closures u ing Student's t test 
for independent measures. Morbidity rates and other 
noncontinuous variables were compared with either a 
X 2 test or Fisher's exact est (one-tailed). Probability 
values were calculated as indexes of amount of effect, 
and thus no corrections for multiple comparisons 
were made for secondary analyses. 
The trial was powered on the basis of event rates 
that were anticipated to occur over the duration of 
the trial. The trial may have been underpowered to
detect 30-day morbidity event rates, which were 
lower than anticipated for the full duration of the 
trial. 
Four patients who were randomized to JVP were 
removed from the trial and treated with PC by their 
surgeons. No follow-up information was provided for 
these patients, therefore they could not be analyzed. 
Three patients who were randomized to JVP closure 
had to undergo closure with SVP; these patients were 
analyzed "as treated," as SVP closure patients. An 
intent-to-treat nalysis was also performed with these 
patients analyzed as they were randomized (as JVP 
patients). No substantial changes in the results were 
observed. 
RESULTS 
There were no statistical differences between the 
demographic and clinical data in the various groups 
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Table II. Perioperative morbidity and mortality data 
Primary closure PTFE dosure SV-P dosure fVP  closure 
(n = 135) (n = 134) (n = 70) (n = 60) Total 
No. (%) No. (%) No. (%) No. (%) No. (%) 
Neurologic omplications 
TIA (ipslateral) 3 (2.2) 3 (2.2) 2 (2.9) 1 (i.7) 9 (2.3) 
RIND (ipsilateral) 1 (0.7) 2 (1.5) 0 1 (1.7) 4 (1) 
CVA (ispsilateral) 6 (4.4) 1 (0.8) 0 0 7 (1.8) 
Crarfial nerves 3 (2.2) 3 (2.2) 1 (1.4) 1 (1.7) 8 (2) 
Dysfunction 
Cardiac complications 
MI 4 (2.9) 1 (0.8) 0 1 (1.7) 6 (1,5) 
Other (CHF) 0 0 2 (2.9) 0 2 (0.5) 
Respiratory complications 
Pneumonia 1 (0.7) 1 (0.8) 0 0 2 (0.5) 
Arrest 0 0 0 1 (1.7) 2[ (0.3) 
Bleeding 0 1 (0.8) 0 1 (i.7) 2 (0.5) 
Death* 2 (1.5) 0 1 (1.4) 1 (1,7) 4 (1) 
Total, 20 (14.8) 12 (8.9) 6 (8.6) 7 (11.7) 45 (11.3) 
*Two deaths inprimary group resulted from myocardial infarction. Two deaths in the vein group resulted from respiratory arrest in one and 
cardiopulmonary rrest in the other. 
"~No statistically significant difference between the groups when all complications were combined. 
(Table I). The perioperative morbidity and mortality 
rates are shown in Table II. There were a total of four 
deaths (i%) and they were not related to strokes; two 
patients in the PC group died of myocardial infarc- 
tions~ and two patients in the VPC group died, one of  
cardiopulmonary arrest and one of respiratory arrest. 
There were no statistically significant differences be- 
tween the various groups when the combined 30-day 
morbidity and mortality rates were compared. One 
patient in the JVP group and one patient in the 
PTFE-PC group had significant neck hematomas 
that required operative vacuation with no further 
complications. There were eight (2%) cranial nerve 
injuries: four to the mandibular branch of  the facial 
nerves, three hypoglossal nerve injuries, and one va- 
gal nerve injury. Five of these cranial nerve injuries 
were temporary (resolved within 30 days), and three 
persisted for more than 30 days. 
Overall, nine patients had TIAs and normal re- 
sults on a postoperative duplex ultrasound scan, ex- 
cept for one patient who had PC. This patient had 
> 50% ICA stenosis, and he refused further interven- 
tion because he had no symptoms beyond the initial 
TLA, which lasted for a few minutes. Four patients 
had RINDs and all had a normal result of the post- 
operative duplex ultrasound scan, except for one 
patient with PC who had postoperative carotid artery 
thrombosis. This patient's deficit was noticed 2 days 
after surgery, and he was treated with anticoagulation 
medication. The other three patients had RINDs that 
were believed to be embolic in nature and they were 
treated with anticoagulation medication. Seven pa- 
tients had permanent CVAs, one in the PTFE-PC 
group and six in the PC group. One of these patients 
awoke with a neurologic deficit ha the operating room 
and an immediate ocular pneumoplethysmography 
(OPG) /Gee was performed, the result of which was 
positive. This patient underwent a thrombectomy 
and PTFE-PC with a significant neurologic improve- 
menr. Four other patients had CVAs in the recovery 
room, where an immediate OPG/Gee and duplex 
ultrasound scan confirmed carotid thrombosis in 
three. These three patients underwent hrombec- 
tomv and PTFE patch angioplasty, with significant 
improvement of their neurologic deficits. The other 
patient had a normal result on a duplex ultrasound 
scan and was treated with anticoagulation medica- 
tion, with some improvement of  the neurologic def~ 
icit. The remaining two other CVAs occurred 24 and 
48 hours after surgery, and both patients had normal 
duplex ultrasound and OPG/Gee results and were 
treated with anticoagulation medication, with some 
neurologic improvement in one and none in the 
other. Computed tomographic scans of  the brain o f  
all seven patients who had permanent CVAs excluded 
hemorrhage before anticoagulation therapy. 
The mean ICA diameter (0.52 cm) in patients 
who had neurotogic deficits was comparable with the 
mean diameter (0.54 cm) of  the whole series. 
Table III summarizes the primary and secondary- 
analyses of the perioperative neurologic events. 
Among the primary analyses, vein patching proved to 
be significantly better than PC in decreasing the 
incidence of  perioperative CVAs (4.4% vs 0%; 20 --- 
0.0165). PTFE-PC exhibited a strong, but statisti- 
cally insignificant, rend toward a lower mddence of  
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Table I I I .  Comparative results ofperioperative n urologic omplications and acute ICA thrombosis 
Complications 
Primary PTFE Vein patch SVP JVP PTFE & vein 
closure closure closure Total closure closure closure 
(n = 135) (n = 134) (n = 130) (n = 399) (n = 70) (n ,= 60) (n = 264) 
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) 
Primary analyses 
CVA only 6 (4.4) 1 (0.8) 0 7 (1.8) 
Secondary analyses 
CVA & RIND 7 (5.2) 3 (2.2) 1 (0.8) l l  (2.8) 
CVA, RIND, & TIA 10 (7.4) 6 (4.5) 4 (3.1) 20 (5) 
ICA Occlusion 5 (3.9) 2 (1.6) 0 7 (1.8) 
CVA, RIND, TIA, & ICA 11 (8.1) 7 (5.2) 4 (3.1) 22 (5.5) 
Occlusion 
CVA, RIND, & ICA Occlusion 8 (5.9) 4 (3) 1 (0.8) 13 (3.2) 
Secondary analyses 
0 0 1 (0.4) 
0 1 (1.7) 4 (1.5) 
2 (2.9) 2 (3.3) 10 (3.8) 
0 0 2 (0.8) 
2 (2.9) 2 (3.3) 11 (4.2) 
0 1 (1.7) 5 (1.9) 
CVA only: PC vs PTFE-PC, p = 0.061; PC vs VPC, p = 0.0165"; PTFE-PC vs VPC, p = 0.51. 
CVA & RIND: PC vs PTFE-PC, p = 0.17; PC vs VPC, p = 0.037; PTFE-PC vs VPC, p = 0.32. 
CVA, RIND, & TIA: PC vs PTFE-PC, p = 0.22; PC vs VPC, p = 0.096; PTFE-PC vs VPC, p = 0.39. 
ICA Occ.: PC vs PTFE-PC, p = 0.22; PC vs VI'C, p = 0.033; PTFE-PC vs VPC, p = 0.26. 
CVA, RIND, TIA & ICA Occ.: PC vs PTFE-PC, p = 0.24; PC vs VPC, p = 0.063; PTFE-PC vs VI'C, p = 0.29. 
CVA, RIND, & ICA Occ.: PC vs PTFE-PC, p = 0.19; PC vs VPC, p = 0.021; PTFE-PC vs VPC, p = 0.19. 
All comparisons between SVP and JVP were nonsignificant. 
PC vs patch: CVA, p = 0.007; CVA & RIND, p = 0.040; CVA, RIND, & TIA, p = 0.19t; CVA, RIND, TIA or occ., p = 0.165; ICA occ., 
p = 0.047; CVA, RIND, & ICA occ., p = 0.065.J 
*Statistically significant. 
l"Chi square test. 
CVA (0.7%; p = 0.061). The rates of postoperative 
CVA were similar for PTFE-PC and for VPC. 
The secondary analyses also compared occur- 
rences of transient neurologic events (TIA and RIND 
data not displayed), combinations of transient events, 
and CVA among the three closure procedures (Table 
III). Although patients who had PC tended to have a 
higher incidence of  combinations of  postoperative 
neurologic events, none of  the incidences were sig- 
nificantly higher than either the PTFE-PC or the 
VPCs. 
Table III also compares PC with all patch closures 
(PTFE-PC and VPC). Postoperative CVA was sub- 
stantially decreased in patch closures compared with 
PC (0.4% vs 4.4%; p = 0.007). There were no differ- 
ences between SVP and JVP closures. There was a 
decreased risk of  acute postoperative ICA occlusion 
in VPCs (0%), in contrast to PCs (3.9%; p = 0.033). 
This decreased risk was also observed in all patches 
(0.8%) when compared with PC (3.9%; p = 0.047). 
The combined rates of CVA, RIND, and ICA occlu- 
sion was lower in VPCs (0.8%) than in PCs (5.9%; p = 
0.021). This finding was a trend in all patches (1.9%) 
versus PCs (5.9%; p = 0.065). 
The mean diameter of  the ICA was not signifi- 
candy different among patients who had postopera- 
tive neurologic complications (TIA, CVA, RIND, 
single or combined) and patients who did not have 
these complications (Table IV). Similar findings were 
noted for patients who had postoperative ICA 
thrombosis or 30-day postoperative --50% ICA ste- 
nosis (Table IV). 
The operative data are shown in Table V. The 
operative time for  the PC group was significantly 
shorter than for the patch group. The operative time 
for VPC in general or SVP closure were not signifi- 
cantly longer than for PTFE-PC. The mean occlusion 
time for shunt placement was similar for all types of  
closure (34 seconds for PC, 36 seconds for PTFE- 
PC, 33 seconds for SVP, and 35 seconds for JVP). 
The mean occlusion time for shunt removal was 
similar also. The hemostasis time was significantly 
shorter for the PC group than for the patch group; 
however, the hemostasis time for the PC group was 
not statistically different from the SVP group. The  
hemostasis time for the VPC group was significantly 
shorter than the PTFE-PC group. 
Table VI, A, illustrates the 30-day postoperative 
ICA stenosis rates according t ° various types of clo- 
sure. Table VI, B, shows the rate of  early postopera- 
tive common carotid artery or ICA significant dilata- 
tion (greater than twice the size). 
DISCUSSION 
CEA is the most common vascular procedure 
performed in the United States, yet there is no gen- 
eral consensus among surgeons regarding the bene- 
fits and roles of patching at the time of surgery. Many 
authorities advocate patch angioplasty after CEA as 
an alternative to PC and cite the following advan- 
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Table IV. Mean ICA diameter (cm) and various complications 
Complications No complications Student's 
(No. SD) (No., SD) t test p* 
All neurologic complications combined 0.518 (20, 0.086) 0.540 (374, 0.076) 0.20 
(TIA, CVA & RIND) 
CVA only 0.38 
CVA & RIND 0.93 
CVA, RIND, Death & ICA occlusion 0.93 
Postoperative ICA occlusion 0.89 
Postoperative ICA stenosis (->50%) 0.46 
0.563 (8, 0.i03) 
0.541 (11, 0.094) 
0.538 (17, 0.082) 
0.536 (7, 0.099) 
0.529 (26, 0.090) 
0.539 (386, 0.077) 
0.539 (383,0.077) 
0.539 (377, 0.077) 
0.540 (367, 0.077) 
0.541 (348, 0.076) 
Two-tailed probability. 
There were no statistically significant differences between these mean values. 
Table V. Mean operative and hemostatis time (SD) according to closure type 
Primary PTFE VPC All SVP JVP All patch 
closure closure closure closures closure closure closures 
Mean operative time 103 (25) 123 (28) 126 (273 117 29) 122 (283 131 (25) 124 ~28) 
in minutes (SD) 
Mean hemostasis time 6 (6.9) i9 (17.1) 8 (7.2) 11 (133 7 (6.1) I0 8.2) 14 ( i4 2)  
in minutes (SD) 
Operative time: PC vs all patching, p < 0.0001; PC vs VCP, p < 0.0001; PC vs PTFE-PC, p < 0.0001; VPC vs PTFE-PC. not significant; 
PC vs SVP, p < 0.0001; PC vs JVP, p < 0.0001; SVP vs JVP, p = 0.05; SVP vs PTFE-PC, not significant: JVP vs PTFE-PC, p = 0.92. 
Hemostatis time: PC vs all patching, p < 0.0001; PC vs VPC, p - 0.11: PC vs PTFE-PC, p < 0.0001: VPC vs PTFE-PC,/9 < 0.0001: PC 
vs SVP, not significant; PC vs JVP, p = 0.002; SVP vs JVP, p = 0.05: SVP vs PTFE-PC, p < 0.0001; JVP vs PTFE-PC, ~o - 0.0005. 
rages: a lower incidence of perioperative stroke and 
carotid artery thrombosis, and a lower incidence of 
recurrent carotid artery stenosis. 3-8,11 It has been 
suggested that the flow characteristic of patched ca- 
rotid arteries may be superior to that of  primary 
closed arteries in terms of  preventing early thrombo- 
sis, 3 which can be attributed to the fact that the 
endarterectomized artery is thrombogenic for the 
first several hours after CEA, during which time the 
carotid artery is most vulnerable to acute thrombo- 
sis. !9 Other authors have attributed this improve- 
ment o a widening of the artery with a corresponding 
reduction in the effect of intimal hyperplasia. 2 Most 
data on patch angioplasty procedures have been 
derived from retrospective or nourandomized pro- 
spective trials. A review of  the English literature de- 
tected only a few prospective randomized studies 
that  compared the results of  CEA with PC versus 
patching.7-9,14,20 
This series is the first prospective randomized trial 
of CEA that compares PC versus PTFE-PC versus 
SVP closure versus JVP closure in 399 consecutive 
CEAs. Our study showed that the perioperative per- 
manent CVA rates were statistically significantly su- 
perior in the patched group when compared with the 
PC group (4,4% for PC, 0.8% for PTFE-PC, and 0% 
for both S~ and JVP closure groups). The periop- 
erative CVA and RIND combined rates in the patch 
group were also statistically superior to the PC group 
(1.5% vs 5.2%). VPC was superior to PC t0.8% vs 
5.2%). 
The perioperative permanent CVA rates for pre- 
vious trials that used PTFE or SVP ranged from 0% to 
2%. 4's'8'9'13 Hcrtzer et al.s reported that the periop- 
eranve CVA rate for 917 primary CEAs was 0.7% in 
patients who underwent SVP closure versus 3.1% in 
patients who underwent PC (p = 0.0084). Others 
have reported conflicting findings in regards to 
patching versus PC. In a study that compared CEA 
with PC, fabric patch angioplasty, and vein patching, 
Fode et al.21 reported a statisncally significant higher 
incidence of CVA and death after PC (6.6%) or fabric 
patches (7%), compared with 2% for VPC. Lord et al., 8 
in a randomized prospective study that compared 
SVP, PTFE-PC, and direct arteriotomy closure after 
CEA, concluded that postoperative n urologic om- 
plications were more frequent in the PC group than 
in the patched group, but the differences were not 
significant. Their series, however, only included 140 
CEAs for all three groups--PC, SVP, and PTFE-PC. 
Others la concluded that the method of carotid clo- 
sure did not appear to affect postoperative CVA rates 
Katz et al.14 demonstrated nosignificant difference in 
the perioperative morbidity and mortality rates be- 
tween PC and PTFE-PC; however, this series included 
only i00 CEAs, with 51 PCs and 49 PTFE4PCs. 
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Table VI, A. 30-day postoperative duplex ultrasound results 
Duplex findings 
Primary PTFE SVP 
closure closure closure closure 
(n = 135) (n = 134) (n = 70) (n = 60) Total 
No. (%) No. (%) No. (%) No. (%) No. (%) 
(1) Normal 110 (81.5) 119 (88.8) 61 (87.1) 49 (81.7) 339 (84.9) 
(2) <50% ICA stenosis 3 (2.2) 6 (4.5) 1 (1.4) 3 (5) 13 (3.3) 
(3) ->50% ICA stenosis 16 (11.9)* 3 (2.2) 2 (2.9) 6 (10) 27 (6.8) 
(4) ->50% to <80% ICA stenosis 11 (8.2) 1 (0.8) 2 (2.9) 5 (8.3) 19 (4.8) 
(5) ->80% ICA stenosis 0 0 0 1 (1.7) 1 (0.3) 
(6) ICA occlusion 5 (3.7) 2 (1.5) 0 0 7 (1.8) 
(7) Not done 6 (4.4) 6 (4.5) 6 (8.6) 2 (3.3) 20 (5) 
p values; > or equal to 50% ICA stenosis: PC vs all patching, p = 0.008; PC vs VPC, p = 0.086; PC vs PTFE-PC, p = 0.0017; SVI' vs 
PTFE-PC, p = 0.54; SVP vs PC, p = 0.028. 
> or equal to 80% ICA stenosis: No statistically significant difference between various closures. 
100% ICA occlusion: PC vs all patching, p = 0.048; PC vs VPC, p = 0.035. 
*This includes all arteries in 4, 5, and 6 categories. 
Table VI, B. 30-day postoperative 
significant dilation 
Primary PTFE SVP JVP 
closure closure closure closure 
CCA dilation* 0% 1% 4% 0% 
ICA dilation* 5% 9% 9% 17%]" 
*Significant dilation means -> twice the size of adjacent normal 
artery. 
1"No statistically significant differences. 
There were four out of 135 cases (3%) of acute 
postoperative ICA thrombosis n the PC group in our 
series, in contrast to 0 out of 130 in the VPC group 
and 1 out of 134 (0.8%) in the PTFE-PC group 
(statistically significant differences). Our findings 
were consistent with those of Ouriel and Greene, 22 
Little et al.,23 and Archie, 3 who reported a 4% peri- 
operative carotid thrombosis rate for the PC group as 
compared with no occlusion in patients who under- 
went SVP angioplasty. 
The increased operative time required for patch 
closure, the risk of patch rupture, the potential for 
false aneurysm formation, and thromboembolism 
from dilated or aneurysmal carotid ilation are factors 
that weigh against carotid patch angioplasty. In the 
early follow-up eriod of our study, these factors were 
not significant except for an increased operative time 
of approximately 21 minutes for patch closure versus 
PC. The increased operative time can be explained by 
an increase in hemostasis time, a longer suture line, 
and the time required for fashioning the patch. This 
increase in operative time can be justified on the basis 
of reduced perioperative stroke rates for patch anglo- 
plasty when compared with PC. Similar findings were 
reported by Katz et al., 14 who reported that an aver- 
age of 19 additional minutes of operative time was 
required for PTFE-PC versus PC, which was consis- 
tent with the findings of other studies.8.11 
It is generally believed that an ICA diameter less 
than 4 mm requires a patch angioplasty to reduce 
perioperative stroke rates and occlusion. Beyond this 
exclusion, however, the size of the ICA was not a 
significant factor in our series. The mean diameter of 
the ICA was similar in patients who had neurologic 
complications and in those who did not. Similarly, 
gender was not a significant factor in the incidence of 
perioperative neurologic omplications in our series. 
The choice of patch material has been controver- 
sial. Factors that affect he selection of patch material 
include the availability, the morbidity associated with 
harvest, the resistance to infection, thrombogenicity, 
aneurysmal formation, and rupture of the patch. 
Many authorities prefer using autologous material 
(saphenous orneck vein; for example, internal jugular 
vein, external jugular vein, facial vein), citing the 
advantages of using an intima-lined patch with the 
potential for reduction of perioperative thrombosis 
and infection. The most important disadvantage of
vein patches in general is the irregularity of their 
mechanical integrity, which varies according to the 
site of harvest. 
An infrequent complication associated with SVPs 
has been a blow-out or rupture in the early postop- 
erative period. 4'5,13,24 In addition, Lord et al. 8 re- 
ported a significant incidence of aneurysmal expan- 
sion of SVPs (17%) as demonstrated bypostoperative 
arteriograms, and therefore they recommended the 
use of PTFE patches preferentially. There was no vein 
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patch rupture in our series, and early postoperative 
dilation was not significantly different from the PC 
group. 
Satisfactory perioperative reports have been ob- 
tained using neck veins, including the internal jugular 
vein, external jugular vein, and facial veins. 15,16,25 
Similar perioperative results were obtained in our 
series, with a 0% perioperative stroke rate; however, 
significant postoperative dilation was noted in 1 7% of 
the JVP group in contrast to 5% of the PC group, but 
the difference was not statistically significant. Because 
this is an early follow-up, close observation should be 
obtained on this type of closure. 
Synthetic patches, including Dacron and PTFE, 
have also been used for carotid angioplasty, and they 
have the advantages of availability, resistance to an- 
eurysmal formation and patch rupture, and the re- 
duction in morbidity that is associated with vein 
harvesting. Excessive intraoperative bleeding from 
needle holes in the PTFE cardiovascular patches has 
been reported. ~1,26 These occurrences have been re- 
lated to the use of needle/suture combinations in 
which the needle is larger in diameter than the suture, 
so that the suture does not completely fill the hole 
made in the patch by the needle. Other studies, 
however, reported no significant bleeding problems 
with PTFE in CEA. 8a3,27 Reduction of such blood 
loss has been found to be associated with a needle/  
suture diameter ratio of 1:1 27,28 and the PTFE suture 
(CV-6) has such a ratio. In our series, using PTFE 
needles (TT-9) and sutures (CV-6) minimized the 
hemostasis time; however, the mean hemostasis time 
for PTFE2PC was still significantly longer than for 
both PC and VPC. 
It was not the purpose of this paper to analyze the 
late recurrent ICA stenosis rates after various CEA 
closures; however, the rate of early postoperative 
stenosis ~50% was significantly higher in patients 
who had PC than in patients who had any patch 
closure in our series. This present study is scheduled 
to continue for at least 1 to 2 years to study the effect 
of  patching on late recurrent stenoses and aneurysmal 
dilation, and these results will be reported at a later 
date. Lord et'al. 8 reported that the incidence of early 
postoperative ICA stenosis was significantly higher in 
the PC group than in the patch group, Others re- 
ported significant early postoperative abnormalities 
after CEA. An extensive review by Barnes et al. 29 on 
intraoperative and postoperativ e evaluation studies 
showed that the percentage of abnormalities in the 
early postoperative p riod varied from 1.1% to 29.1%. 
Eil;elboom 7 reported that many of  the early lesions 
disappeared during follow'up. A shelf is often present 
at the beginning of the endarterectomy in the com- 
mon carotid artery, and this shelf usually smooths out 
in tame. They also showed, however, that significant 
i-year stenos~s was present in 31% of patients who 
had residual esions and in only 8% of patients who 
had normal results on postoperative digital subtrac- 
tion angiograms. 
This randomized prospective study confirms the 
conclusions of several other investigators that patch- 
ing in general is superior to PC in lowering the 
incidence of perioperative CVA and acute postoper- 
ative ICA thrombosis. Both VPC and PTFE-PC were 
superior to PC in this regard. Patching (PTFE or 
SVP) was also significantly superior in lowering the 
incidence of early postoperative carotid artery steno- 
sis, and maybe potentially superior in reducing signif- 
icant recurrent carotid artery stenosis over the long 
term. There was a tendency toward a higher inci- 
dence of ICA dilation in the JVP group in contrast to 
PTFE-PC. Therefore, we conclude that when patch- 
ing is deemed necessary, SVP or PTFE may be appro- 
priate. Further long-term follow-up is needed to 
verify this conclusion, and this follow-up will be 
reported at a later date. 
We acknowledge the assistence of A. R. Cafoncelli, 
MD, M Z. Khan, MD. F. S. Malik, MD, IC C. Lee. MD, 
and E. H. Tiley III. MD. 
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DISCUSSION 
Dr. Robert W. Hobson I I  (Newark, N.J,). Dr. Abu- 
Rahma and his colleagues report on a series of 399 CEAs 
that were performed uring a recent 4-Year period in which 
closure of the carotid arteriotomy was randomized to PC 
versus PTFE patch closure versus VPC, and in which they 
alternated the use of autogenous saphenous vein from the 
anlde and the internal jugular vein. The authors conclude 
that patch closure is significantly ess associated with post- 
operative stroke, death, and immediate postprocedural ICA 
stenosis than is PC. Although these carefully analyzed ata 
confirm my biases about the superiority of patch closure, 
with the possible exception of male patients whose ICA 
diameter exceeds the 4- to 5-mm range, the authors' data 
appear to suggest that we are still in search of the ideal patch 
material. 
Several questions seem appropriate. What is the gender 
distribution within your clinical series? As we know from 
the Asymptomatic Carotid Atherosclerosis Study data, op- 
eration on women who have asymptomatic carotid stenosis 
was associated with a higher perioperative complication 
rate. Is it possible that you had a higher concentration f 
women in the PC group and therefore skewed your data? 
Although this was a preliminary report, a 30May peri- 
operative observation period, can you provide us with some 
additional follow-up on your duplex data regarding reste- 
nosis? Clearly, the motivation for patching has to have 
something to do with preventing long-term restenosis, and 
we wonder if your data confirmed this? 
In our practice, we continue to use PC in male patients 
who have ICAs whose transverse diameter is in excess of 4- 
to 5-mm. On the basis of your data, however, do you 
recommend the use of PC in any patient? 
What is the ideal patch material for closure? Have you 
considered Dacron, or even possibly the everted external 
jugular vein, as recommended byDardik and colleagues? If
the synthetic patches are as good as autologous veins, and 
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that is certainly suggested by your report, why not use 
Dacron to avoid the excessive needle-hole bleeding that is 
associated with PTFE? This would also avoid the anecdotal 
reports with regard to vein patch rupture, particularly as 
seen with anlde vein harvesting, which you used m your 
report, as well as postoperative dilatation. 
This report confirms the value of  carotid patch angio- 
plasty and CEA. Although its use will lengthen the time of 
operation by about 20%, we agree with your conclusion and 
are indebted to you for bringing these well-documented 
data to our attennon. 
Dr.  All  F. AbuRaluna.  In terms of the gender factor, 
the male to female ratio was comparable in types of  closure. 
primary or patch closure. In regard to late postoperative 
duplex ultxasound ata. I do not have a definite answer at 
this stage; however, some of  the patients who had PC 
underwent aredo CEA during follow-up. I am hoping that 
by the end of this year, I will be able to collect all of  the 
necessary data. scrutinize it, and analyze it scientifically to 
determine whether the late recurrence rate is slgnificantly 
higher m patients with PC. Because I have to give you an 
educated guess at this tage, 1will not be surprised if PC has 
a higher recurrent stenosis rate han patch closure. 
In response to your third question regarding the diana- 
eter of  the artery, the mean size of  the 1CA for patients with 
or without neurologic complications was comparable, and 
on the basis of  the early data, we were unable to determine 
a specific size wherein PC was as safe as a patch closure. As 
I indicated earlier, however, we will have more facts and 
figures after we have completed our late follow-up on these 
patients. I an  hoping that we will be able to choose certain 
parameters, whether gender or the size of  the artery, that 
might be used as factors to determine whether PC is as 
dtEctive as a patch closure in regard to late recurrent 
stenosis. 
What is the ideal patch? On the basis of  our data, there 
was no significant difference between autologous nssue and 
PTFE patches. I have not used the Dacron patch, so I 
cannot answer your question regarding this type of  patch. 
Dr. Carol  A. Raviola (Philadelphia, Pa.L I have sev- 
ern questions relative to the intraoperative aspects of  these 
particular cases. Were there any differences in your three 
categories in the length of  the endarterectomy, particularly 
of  the ICA? Were there any end-point problems in any of  
these three categories, and specifically, were end-points 
tacked down in one group more than in another? 
Was any intraoperative vascular imaging performed 
before the patient left the operating room such that you 
knew for certain that all groups were comparable (patent, 
had no end-point problems, no flaps) at the time of closure? 
Dr.  AbuRahma.  I am not aware o f  any significant 
difference in the length of  the CEA between patients who 
underwent PC and those who underwent patch closure. 
There was no specific intraoperative imaging performed in 
the patients m this series, except for patients who had 
neurologic deficits in the operating room, the recovery 
room, or before discharge. Of  course, all patients under- 
went a 30-day postoperative duplex ultrasound scan, 
Dr. Enr ico Aseer Brooldyn, N.Y. 1. I rise to defend the 
PC somewhat. We have performed 408 cases in the last 31/2 
years, and I would say that 92% of them were PCs. We patch 
basically in patients who have redundant carotid arteries, 
after we plicated, and for a very, very small ICA. almost a 
string sign. In all other patients we close primarily 
We have not seen a single thrombosis. Actually throm- 
bosis is a very rare phenomenon, if you Iook at the New 
York University data, and I wonder why you achieved 4% of 
thrombosis. About 1 out of  25 patients had thrombosis of
the 1CA. I think that's a very high incidence of  thrombosis, 
and I wonder if the group that is performing this random- 
ized study is not the one that used the patch routinely, and 
then thev went into doing the study and started doing the 
PCs. I think that with a lot of experience in the PC. you 
should decrease this incidence dramatically and, therefore. 
you may not find a significant difference 
Dr. AbuRahma.  That is a good question, Dr. Ascer. I 
do not really know the answer to this question; however, I 
would like to look into this and determine whether it was a 
factor. I doubt that this was a factor, however, because 
more than two thirds of  the procedures were performed by 
me. and the remaining third were performed by a few other 
surgeons. I am not sure that the types of  closure and 
pracnces used by the surgeons in this series were a W 
different from that to which they were accustomed. 
Dr.  John  J. Ricotta (Buffalo, N.Y.) Dr. AbuRahma, 
that was a very nice presentation. I may have missed the 
answer to this question: Was the diameter of the patch 
when you implanted it identical in all of  the cases? Did you 
trim it so that the vein patch and the PTFE were the same 
diameter when they went in? 
Dr.  AbuRahma.  That is an excellent point. The diam- 
eter of  the patch was roughly between 5 and 6 mm, and the 
patch was designed in such a way as to keep the carotid bulb 
and bifurcation as it was before the endarterectomy was 
performed. There was no significant discrepancy bet~veen 
the size of  the patches used. 
